FGFR3 is involved in tumorigenesis in ∼40% of invasive bladder cancer and in the majority (∼80%) of low-grade non-invasive (stage Ta) bladder cancers [59]. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.